RETATRUTIDE: ONE THOROUGH EXAMINATION

The novel class of GLP-1 receptor agonist and GIP combined medications, including tirzepatide, semaglutide, and the relatively introduced retatrutide, represent promising improvements in diabetes treatment . Although all three operate by influencing blood levels , they vary in their unique mechan